首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3519146篇
  免费   305200篇
  国内免费   14131篇
耳鼻咽喉   47904篇
儿科学   112697篇
妇产科学   92462篇
基础医学   561603篇
口腔科学   93797篇
临床医学   317285篇
内科学   628230篇
皮肤病学   93359篇
神经病学   304078篇
特种医学   137877篇
外国民族医学   490篇
外科学   541419篇
综合类   107619篇
现状与发展   24篇
一般理论   2348篇
预防医学   295325篇
眼科学   80588篇
药学   241817篇
  19篇
中国医学   10477篇
肿瘤学   169059篇
  2021年   55292篇
  2020年   35284篇
  2019年   58313篇
  2018年   71797篇
  2017年   54542篇
  2016年   60319篇
  2015年   74098篇
  2014年   108420篇
  2013年   173577篇
  2012年   99480篇
  2011年   99970篇
  2010年   118032篇
  2009年   122390篇
  2008年   86592篇
  2007年   90297篇
  2006年   100699篇
  2005年   95910篇
  2004年   97297篇
  2003年   87693篇
  2002年   77135篇
  2001年   118127篇
  2000年   111578篇
  1999年   107534篇
  1998年   66661篇
  1997年   64237篇
  1996年   62086篇
  1995年   57528篇
  1994年   51471篇
  1993年   48036篇
  1992年   74196篇
  1991年   69869篇
  1990年   65609篇
  1989年   64404篇
  1988年   59365篇
  1987年   58073篇
  1986年   54616篇
  1985年   54413篇
  1984年   49488篇
  1983年   45059篇
  1982年   42165篇
  1981年   39545篇
  1980年   37234篇
  1979年   40223篇
  1978年   35566篇
  1977年   32277篇
  1976年   29612篇
  1975年   27937篇
  1974年   29006篇
  1973年   28027篇
  1972年   26228篇
排序方式: 共有10000条查询结果,搜索用时 93 毫秒
171.
172.
173.
174.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
175.
176.
177.
178.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
179.
Chondrocytes are the main cells in the extracellular matrix (ECM) of articular cartilage and possess a highly differentiated phenotype that is the hallmark of the unique physiological functions of this specialised load-bearing connective tissue. The plasma membrane of articular chondrocytes contains a rich and diverse complement of membrane proteins, known as the membranome, which defines the cell surface phenotype of the cells. The membranome is a key target of pharmacological agents and is important for chondrocyte function. It includes channels, transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and ECM proteins and other macromolecular complexes. The chondrocyte channelome is a sub-compartment of the membranome and includes a complete set of ion channels and porins expressed in these cells. Many of these are multi-functional proteins with “moonlighting” roles, serving as channels, receptors and signalling components of larger molecular assemblies. The aim of this review is to summarise our current knowledge of the fundamental aspects of the chondrocyte channelome, discuss its relevance to cartilage biology and highlight its possible role in the pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, an inflammatory micro-environment, alternative splicing of channel components or accumulation of basic calcium phosphate crystals can result in an altered chondrocyte channelome impairing its function. Alterations in Ca2+ signalling may lead to defective synthesis of ECM macromolecules and aggravated catabolic responses in chondrocytes, which is an important and relatively unexplored aspect of the complex and poorly understood mechanism of OA development.  相似文献   
180.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号